EDAP-TMS FRANCE
Location
AUVERGNE RHONE ALPES
Founded
1994-02-23
Website
Risk Signals
28 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Executive Leadership Changes (8)
Financial Reporting (4)
Corporate Governance Policies (4)
Recruitment Activities (3)
Stock Market Events (3)
Earnings Reports & Warnings (3)
Business Growth Initiatives (2)
Corporate Announcements (2)
Issuing Shares (2)
Manufacturing Disruptions (2)
Business Resilience Planning (2)
Equity Analysis & Ratings (2)
Funding Announcements (2)
Workplace Ethics & Policies (1)
Corporate Awards and Recognitions (1)
Corporate Financial Crises (1)
Healthcare Compliance and Regulations (1)
Inter-Organizational Collaborations (1)
Market Entry (1)
Market Trends (1)
New Product Release (1)
Political and Economic Developments (1)
Tech Innovation & Advancements (1)
Workforce Reductions (1)
Access and Affordability Initiatives (1)
Recent Articles about EDAP-TMS FRANCE
Live alerts from global media, monitored by Business Radar
(massdevice.com)
Press Release: EDAP completes FDA inspection of manufacturing site
LYON, France -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the U.S. Food and Drug Administration (FDA) concluded its routine inspection of EDAP's manufacturing site with no findings nor issuance of Form 483 observations.
Read more